What the folinic acid retraction means for autism treatment
On January 29, 2026, the European Journal of Pediatrics formally retracted what had been the largest randomized clinical trial examining folinic acid as an intervention for autism. The reason, according to the journal’s notice, was direct: The study’s data did not support its published conclusions.
Originally released in 2024, the trial reported that 24 weeks of oral folinic acid therapy produced a “significant reduction” in autism symptoms among 77 children. In …
What the folinic acid retraction means for autism treatment












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)


![Reclaiming human dignity as the foundation of medical practice [PODCAST]](https://kevinmd.com/wp-content/uploads/69d6a50a-000c-4d2d-9140-35d462146157-190x100.jpeg)



